Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines

Preventive Medicine

Volumn 63, Issue , 2014, Pages 81-86

  Tsui, Jennifer ^a   Hofstetter, Annika M ^b   Soren, Karen ^a,b  

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

Author keywords

Cervical cancer; Guideline adherence; Papanicolaou test

Indexed keywords

ADOLESCENT; ADULT; AGE; AMBULATORY CARE; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; ELECTRONIC MEDICAL RECORD; FAMILY PLANNING; FEMALE; HEALTH CENTER; HUMAN; INSURANCE; LANGUAGE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICALLY UNINSURED; PAPANICOLAOU TEST; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UTERINE CERVIX CYTOLOGY; VACCINATION; YOUNG ADULT; COMPARATIVE STUDY; EARLY DIAGNOSIS; MASS SCREENING; MINORITY GROUP; POVERTY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS;

ADOLESCENT; ADULT; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; GUIDELINE ADHERENCE; HUMANS; MASS SCREENING; MINORITY GROUPS; NEW YORK CITY; PAPANICOLAOU TEST; POVERTY; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84897445635     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.03.010     Document Type: Article

References (34)

1. American Congress of Obstetricians and Gynecologists ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet. Gynecol. 2009, 114(6):1409-1420.
2. Andersen R.M. Revisiting the behavioral model and access to medical care: does it matter?. J. Health Soc. Behav. 1995, 36(1):1-10.
3. Anderson K.J., Speranza P.D. Procedural and temporal compliance to cervical cancer screening guidelines in a CDC-funded program in Alaska. J. Low. Genit. Tract Dis. 2011, 15(2):98-104.
4. Anhang Price R., Koshiol J., et al. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine 2011, 29(25):4238-4243.
5. Bauch C.T., Li M., et al. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?. Lancet Infect. Dis. 2010, 10(2):133-137.
6. Benard V.B., Saraiya M.S., et al. Cancer screening practices among physicians in the national breast and cervical cancer early detection program. J. Womens Health (Larchmt) 2011, 20(10):1479-1484.
7. Community Preventive Services Task, F Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening. Am. J. Prev. Med. 2012, 43(1):92-96.
8. Fauci J.M., Schneider K.E., et al. Referral patterns and incidence of cervical intraepithelial neoplasia in adolescent and pregnant patients: the impact of the 2006 guidelines. J. Low. Genit. Tract Dis. 2011, 15(2):124-127.
9. Hawkins N.A., Benard V.B., et al. Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers. Prev. Med. 2013, 57(5):641-645.
10. Henderson J.T., Saraiya M., et al. Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev. Med. 2013, 56(1):25-29.
11. Ho G.Y., Bierman R., et al. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 1998, 338(7):423-428.
12. Kahn J.A., Slap G.B., et al. Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol. 2007, 26(2):192-200.
13. Kim J.J., Sharma M., et al. Optimal interval for routine cytologic screening in the United States. JAMA Intern. Med. 2013, 173(3):241-242.
14. Kyrgiou M., Koliopoulos G., et al. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006, 367(9509):489-498.
15. Massad L.S., Einstein M.H., et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J. Low. Genit. Tract Dis. 2013, 17(5 Suppl. 1):S1-S27.
16. Metroka A.E., Hansen M.A., et al. Using an immunization information system to improve accountability for vaccines distributed through the Vaccines for Children program in New York City, 2005-2008. J. Public Health Manag. Pract. 2009, 15(5):E13-E21.
17. Moore K., Cofer A., et al. Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am. J. Obstet. Gynecol. 2007, 197(2):141. (e141-146).
18. Moscicki A.B., Shiboski S., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr. 1998, 132(2):277-284.
19. Moscicki A.B., Ma Y., et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet. Gynecol. 2010, 116(6):1373-1380.
20. Moy B., Polite B.N., et al. American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J. Clin. Oncol. 2011, 29(28):3816-3824.
21. Moyer V.A. on behalf of the U.S. Preventive Services Task Force, Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. 2012, 156(12):880-891.
22. New York City Department of City Planning Manhattan Community District 12 - Neighborhoods: Inwood, Washington Heights 2012, (from Available at: http://www.nyc.gov/html/dcp/html/neigh_info/mn12_info.shtml).
23. Perkins R.B., Jorgensen J.R., et al. Adherence to conservative management recommendations for abnormal pap test results in adolescents. Obstet. Gynecol. 2012, 119(6):1157-1163.
24. Perkins R.B., Anderson B.L., et al. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. Am. J. Prev. Med. 2013, 45(2):175-181.
25. Roland K.B., Benard V.B., et al. Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in federally qualified health centers. Prev. Med. 2013, 57(5):419-425.
26. Roland K.B., Benard V.B., et al. Cervical cancer screening among young adult women in the United States. Cancer Epidemiol. Biomarkers Prev. 2013, 22(4):580-588.
27. Saslow D., Runowicz C.D., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin. 2002, 52(6):342-362.
28. Saslow D., Castle P.E., et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J. Clin. 2007, 57(1):7-28.
29. Soren K., Kharbanda E.O., et al. A 6-year experience with Pap smears in an urban adolescent practice: the scope and burden of abnormalities. J. Pediatr. Adolesc. Gynecol. 2009, 22(4):217-222.
30. Tiro J.A., Saraiya M., et al. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer 2008, 113(10 Suppl.):3013-3030.
31. Vawdrey D.K., Natarajan K., et al. Informatics lessons from using a novel immunization information system. Stud. Health Technol. Inform. 2013, 192:589-593.
32. Verani J.R., Irigoyen M., et al. Influenza vaccine coverage and missed opportunities among inner-city children aged 6 to 23months: 2000-2005. Pediatrics 2007, 119(3):e580-e586.
33. Wright T.C., Massad L.S., et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J. Low. Genit. Tract Dis. 2007, 11(4):223-239.
34. Yabroff K.R., Zapka J., et al. Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol. Biomarkers Prev. 2011, 20(12):2471-2479.